GLP-1 receptor agonists, like Wegovy and Ozempic, have taken center stage in obesity and diabetes treatment, praised for their ability to curb appetite, reduce “food noise,” and slow digestion ...

Experts aren’t sure what the outcome of the DOJ’s recent lawsuit against the proposed UnitedHealth Group/Amedisys merger will be under the incoming Trump administration. The Biden administration has ...

NationsBenefits, a fintech, benefits and outcomes platform, has acquired food-as-medicine company Good Measures, the companies announced Tuesday. Plantation, Florida-based NationsBenefits is a ...

Checkpoint inhibitors transformed cancer treatment, bringing to patients immunotherapies now widely used to treat a range of tumors. But there are different types of checkpoints that interact with ...

Several telehealth advocates are coming out in support of the Drug Enforcement Administration’s (DEA) third extension of Covid-19 telehealth flexibilities for the prescribing of controlled ...

The rise of AI changes many spheres of life, with a projected growth rate of nearly 37% by 2030 — while healthcare is expected to see the most impact from AI use with a long-term adoption rate ...

Providers across the nation are continuing their work to make value-based care at scale a reality. One of the most recent examples of this comes from Emory Healthcare in Atlanta — on Monday, the ...

The overall market for specialty medications has grown dramatically over the past decade, and that trend is expected to continue for at least the next five years. Health systems, patients and ...

When you walk into a doctor’s office or a hospital, you don’t even think twice about the machines that your healthcare professionals are using to treat you. It’s an inherent trust that ...

Vaginal discomfort is one of the most common reasons women seek healthcare advice, but standard care isn’t always meeting patients’ needs. That’s why Evvy, a vaginal microbiome startup, has ...

Medicine stands at a remarkable crossroads. The explosive growth in specialty drug development marks a new golden age of therapeutic innovation. In 1990 there were just 10 specialty drugs on the ...